Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2003 Apr;41(4):1651–1655. doi: 10.1128/JCM.41.4.1651-1655.2003

New Pathogenicity Marker Found in the Plasticity Region of the Helicobacter pylori Genome

Adriana Santos 1,2,3, Dulciene Maria Magalhães Queiroz 2,*, Armelle Ménard 1, Armelle Marais 1, Gifone Aguiar Rocha 2, Celso Affonso Oliveira 2, Ana Margarida Miguel Ferreira Nogueira 4, Milton Uzeda 3, Francis Mégraud 1
PMCID: PMC153914  PMID: 12682156

Abstract

Comparison of gastric carcinoma and gastritis isolates showed the presence of genes, probably carcinoma associated (JHP947 and JHP940), that are situated in a Helicobacter pylori genome region (45 kb in J99 and 68 kb in 26695) called the “plasticity region.” This region presents a great variability of DNA sequences. We investigated, by PCR, the presence of the JHP940 and JHP947 genes, as well as the presence of a third gene which seems to be associated with gastritis (HP986), on H. pylori strains isolated from 200 Brazilian patients, 79 of whom had gastric carcinomas and 53 of whom had duodenal ulcers, to confirm this association. Gastritis isolates (n = 68) were included as a control. We also evaluated if these genes were related to the virulence-associated cagA genotype. The present methodology did not permit definitive conclusions to be reached regarding the association between the JHP940 gene and gastric carcinoma or between the HP986 gene and gastritis. However, we showed that the JHP947 gene might be implicated in the development of both duodenal ulcer and gastric carcinoma. The presence of the JHP947 gene was associated with the cagA-positive genotype. The JHP947 gene is a novel virulence marker candidate of H. pylori.


Helicobacter pylori is a gram-negative, spiral, microaerophilic bacterium that lives for decades in the hostile environment of the human stomach. H. pylori infection has a worldwide distribution, and its prevalence ranges from 2% in developed countries to more than 90% in developing areas (17). This bacterium is the major cause of chronic gastritis and plays an important role in the pathogenesis of peptic ulcer disease, gastric carcinoma, and gastric mucosa-associated lymphoid tissue lymphoma (11, 13, 15, 16, 21, 24, 33). However, why only a minority of H. pylori-positive patients develop the severe associated diseases remains unclear. Variation in clinical outcomes has been attributed to differences in environmental factors, bacterial strains, and host genetics. Indeed, a family history of gastric cancer per se, but also in combination with H. pylori infection, is associated with an increased risk for gastric carcinoma (19). With regard to the bacterial factors, the influence of particular genes on the outcome of the associated disease (cagA, vacA, babA, and iceA) has been evaluated in several studies (25, 26, 29, 34). The cytotoxin-associated gene (cagA) was the first one found to be differentially present in H. pylori isolates and is considered a marker for the presence of the cag pathogenicity island (cag PAI). This region includes a number of other genes associated with increased virulence and severe clinical outcomes (5, 22).

Comparison of the genomic contents of two H. pylori strains (26695 and J99) (1) has revealed, in addition to the cag PAI (5), the presence of regions with different G+C contents, which may represent potential PAIs. Among these (there are eight in 26695 and nine in J99) is one so-called “plasticity region” (2), a large region of 45 kb in strain J99 and 68 kb in strain 26695; it encodes 38 genes in J99, of which 33 are absent in 26695.

A recent study conducted by Occhialini et al. (23) on 17 H. pylori strains isolated from patients with gastric adenocarcinoma and 26 H. pylori strains isolated from patients with chronic gastritis-associated dyspepsia allowed the identification of two new potential pathogenicity markers in the plasticity region. Indeed, these genes were found more frequently in gastric cancer strains than in strains isolated from patients with gastritis only. One of the genes (JHP940) was detected only in some strains from patients with gastric carcinoma, and the second gene (JHP947) was found more frequently in strains from patients with gastric cancer (64.7%) than in strains from those without (34.6%). Moreover, a third gene (HP986), which is specific to strain 26695, was highlighted: it was detected more often in strains isolated from patients with chronic gastritis-associated dyspepsia (38.5%) than in strains isolated from cancer patients (11.8%).

However, the authors did not evaluate the presence of these new putative virulence markers in strains isolated from peptic ulcer patients. Furthermore, the associations that they observed need to be confirmed on a greater number of strains as well as in another geographic region, since geographic differences with regard to virulence genes of H. pylori have been demonstrated (3, 4, 7, 9, 12).

Therefore, the aim of the present study was to evaluate the association between new putative virulence genes and two severe diseases with different outcomes associated with H. pylori infection (duodenal ulcer and gastric carcinoma), controlling for confounding factors such as the age and gender of the patients. The pattern of gastritis associated with the infections caused by strains with or without these genes was also studied.

MATERIALS AND METHODS

Clinical samples, bacterial strains, and culture.

This study was approved by the Ethics Committee of the University Hospital, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil, and consent to participation was obtained from all patients. H. pylori strains were isolated from the gastric biopsy mucosae of 200 patients who underwent endoscopy for evaluation of symptoms related to the upper gastrointestinal tract (duodenal ulcer [n = 53] or gastritis associated with non-ulcer dyspepsia [n = 68]) or who underwent gastric surgery to remove a gastric carcinoma (n = 79) at the University Hospital, UFMG, or at the Luxemburgo Hospital of Oncology, Belo Horizonte, Brazil. Characteristics of the patients are presented in Table 1.

TABLE 1.

Characteristics of the patients

Disease No. of patients
Mean age (yr) ± SD (range)
Male Female Total
Chronic gastritis 24 44 68 48.85 ± 15.40 (16-88)
Duodenal ulcer 21 32 53 41.53 ± 15.62 (15-74)
Gastric carcinoma 53 26 79 61.15 ± 13.42 (32-87)
    Total 98 102 200 51.77 ± 16.73 (15-88)

Tissue samples for culture were ground separately in a tissue homogenizer (Kontes, Vineland, N.J.) and plated onto petri dishes containing freshly prepared Belo Horizonte medium (28). Incubation was performed at 37°C under a microaerobic atmosphere obtained by using a gas generation system (Anaerocult C; Merck, Darmstadt, Germany). Plates were evaluated after 3, 6, 9, and 12 days of incubation. H. pylori was identified by macroscopic and microscopic morphology, a positive urease test, positive oxidase and catalase reactions, and PCR amplification of the ureA gene.

The two H. pylori strains whose genomes were sequenced previously (2, 31) were included as controls: strain J99, isolated from a patient with duodenal ulcer, and strain 26695 (NTCC 12455), isolated from a dyspeptic patient with gastritis.

For extraction of total DNA, the H. pylori strains were thawed, plated onto brain heart infusion agar plates supplemented with 10% sheep blood, and incubated at 37°C under microaerobic conditions for 3 days. Cells were harvested in 500 μl of sterile distilled water and centrifuged at 6,000 × g for 5 min, and the pellets were stored at −80°C until processing.

DNA extraction from bacterial cultures.

H. pylori DNA was extracted with the QIAamp tissue kit (QIAGEN Inc., Santa Clarita, Calif.) according to the manufacturer's recommendations, with minor modifications (20). Briefly, the bacterial pellets, stored at −80°C, were suspended in 180 μl of lysis buffer (buffer ATL) and homogenized by vortexing. Twenty microliters of a proteinase K solution (20 mg/ml) was then added, followed by overnight incubation at 56°C. A second lysis buffer (buffer AL) provided in the kit was added, and the sample was incubated at 70°C for 10 min. Next, 200 μl of ethanol was added, and this mixture was then loaded onto the QIAamp spin column and centrifuged at 6,000 × g for 1 min. The QIAamp spin column was placed in a 2-ml collection microtube, and the contained filtrate was discarded. The column material was washed twice (250 μl each time) with the first washing buffer (buffer AW1) and twice (250 μl each time) with the second washing buffer (buffer AW2) provided in the kit. Finally, the DNA was eluted with 100 μl of distilled water preheated to 70°C (two elutions, each with 50 μl). The DNA concentration was determined by measuring the absorbance at 260 nm.

Amplification of DNA by PCR.

Oligonucleotide primers were designed on the basis of published sequences of H. pylori ureA (6), cagA (two sets of synthetic oligonucleotide primers were used, and strains were considered to be cagA positive when at least one of the reactions was positive) (32), and specific open reading frames (ORFs) (JHP940, JHP947, and HP986) from the plasticity region (23) (Table 2). Amplification of H. pylori genomic DNA sequences was carried out in a total volume of 50 μl containing 5 μl of 10× PCR buffer (Eurobio, Les Ulis, France), 1.5 mM MgCl2, 200 μM each deoxynucleotide (Eurobio), 2 U of Eurobiotaq DNA polymerase (Eurobio), 0.5 μM each primer, and 10 ng of H. pylori DNA. Each reaction mixture was amplified for 35 cycles (except for the cagA gene [40 cycles]) as follows: 1 min at 94°C, 1 min of annealing at either 60°C (for cagA and JHP947), 58°C (for HP986), 56°C (for JHP940), or 45°C (for ureA), and 1 min at 72°C. After the last cycle, extension was continued for another 7 min. Amplicons were analyzed on a 1% agarose gel stained with ethidium bromide.

TABLE 2.

Oligonucleotide primers used for PCR

Gene Nucleotide positions Sequence (5′→3′) Size of PCR product (bp) Reference
ureA 304-321 GCCAATGGTAAATTAGTT 411 6
697-714 CTCCTTAATTGTTTTTAC
cagA 157-181 GATAACAGGCAAGCTTTTGAGGGA 394 32
527-550 CCATGAATTTTTGATCCGTTCGG
910-935 ATGGGGAGTCATGATGGCATAGAACC 717 32
1602-1626 ATTAGGCAAATTAAAGACAGCCACC
JHP940 139-158 GAAATGTCCTATACCAATGG 591 23
711-729 CCTAAGTAGTGCATCAAGG
JHP947 91-109 GATAATCCTACGCAGAACG 611 23
682-701 GCTAAAGTCATTTGGCTGTC
HP986 21-39 GCATGTCCCAAATCGTAGG 566 23
568-586 TGCATTTCGCATTGGCTCC

Histological study.

Samples of the antral and oxyntic gastric mucosae were fixed in 10% formalin and embedded in paraffin wax by routine methods. Five-micrometer-thick histological sections stained with hematoxylin and eosin were obtained for histological analysis. The mucosae were analyzed in terms of the degree of inflammatory reaction and activity, which were scored as follows, according to the revised Sydney system (8): 0, none; 1, mild; 2, moderate; 3, marked. For patients with gastric carcinoma, multiple biopsy specimens were obtained from the tumor lesion to confirm the diagnosis.

Statistical analysis.

Data were analyzed with the SPSS statistical software package (version 10.0; SPSS Inc., Chicago, Ill.).

Variables such as gender, mean age, JHP947 gene status (negative or positive), cagA status (negative or positive), and the intensity and activity of antral and oxyntic gastritis (scored as defined above) were evaluated.

Data were examined by logistic regression analysis for association of JHP947 gene status (the dependent variable) with disease (gastritis versus duodenal ulcer versus gastric carcinoma), with adjustments made for potential confounding factors such as age and gender.

Logistic regression analysis was also performed to analyze the relation between the presence of a duodenal ulcer or gastric carcinoma and the JHP947 and cagA status, with adjustments made for age and gender.

For patients without a duodenal ulcer or gastric carcinoma, data were evaluated by logistic regression analysis for association between the severity of antral and oxyntic gastritis and JHP947 gene status, with adjustments made for cagA status.

A P value of ≤0.20 in the univariate analysis was used as a significant level for inclusion in the full model. In the multivariate analysis, a P value of ≤0.05 was considered significant. The odds ratios (OR) of significant covariates, as well as their 95% confidence intervals (95% CI), were determined.

RESULTS

Distribution of the JHP940, JHP947, and HP986 ORFs.

The JHP940 gene was found in only 3 of 200 H. pylori strains isolated, which were from 1 patient with gastritis, 1 with a duodenal ulcer, and 1 with gastric carcinoma. Low frequency was also observed for HP986: this gene was not found in strains isolated from gastritis or duodenal ulcer patients and was present in only 4 of 79 (5.1%) strains isolated from patients with gastric carcinoma. On the other hand, the JHP947 gene was found in 140 (70.0%) of the H. pylori strains analyzed.

Study of the association between JHP947 and severe diseases.

Thirty (44.1%) of the 68 patients with gastritis, 42 (79.2%) of the 53 patients with duodenal ulcer, and 68 (86.1%) of the 79 patients with gastric carcinoma were colonized by a JHP947-positive strain.

In the univariate analysis, when patients with gastritis and gastric carcinoma were compared, the presence of the JHP947 gene was positively associated with gastric carcinoma (P < 10−3), old age (P = 0.14), and male gender (P = 0.047). In the multivariate analysis, the presence of the JHP947 gene remained associated only with gastric carcinoma (P < 10−3; OR, 2.94; 95% CI, 1.86 to 4.64). In the groups of patients with duodenal ulcer and gastritis, the JHP947 gene was associated only with duodenal ulcer disease (P < 10−3; OR, 4.84; 95% CI, 2.13 to 10.96).

Diseases and JHP947 and cagA status.

Among the 140 H. pylori strains harboring the JHP947 gene, 127 (90.7%) were also cagA positive. Since the presence of the JHP947 gene was associated with the cagA-positive genotype (P = 0.01), we investigated whether or not the cagA and JHP947 genes were independently associated with duodenal ulcer and gastric carcinoma by logistic regression, adjusting for confounding factors. The results of the univariate analysis showed that old age, cagA+ status, and JHP947 gene-positive status were associated with gastric carcinoma (P < 10−3 for all variants) and duodenal ulcer (P = 0.01 for age; P < 10−3 for the other variables). With respect to gender, no association was seen with duodenal ulcer (P = 0.62), but male gender was associated with gastric carcinoma (P < 10−3).

In the multivariate analysis, the cagA and JHP947 genes were independently associated with duodenal ulcer. These genes were also independently associated with gastric carcinoma. Old age and male gender of the patients were also independently associated with gastric carcinoma but not with duodenal ulcer (Table 3).

TABLE 3.

Variables associated with gastric carcinoma and duodenal ulcer diseases in the multivariate analysis

Variable Finding for:
Gastric carcinoma
Duodenal ulcer
OR 95% CI P OR 95% CI P
Old age 1.07 1.04-1.10 0.000 0.98 0.95-1.00 0.059
Male gender 0.32 0.14-0.74 0.008
cagA-positive status 4.67 1.56-13.97 0.006 4.51 1.56-13.06 0.005
JHP947 gene-positive status 4.14 1.47-11.66 0.007 2.75 1.08-6.96 0.033

cagA status, JHP947 status, and gastric mucosa histology.

We also evaluated whether the presence of the cagA and JHP947 genes in the H. pylori strains was associated with the severity of gastritis in the subset of patients without duodenal ulcer or gastric carcinoma.

In the univariate analysis, the presence of the JHP947 gene was associated with cagA-positive status (P < 10−3), the activity (P = 0.002) of oxyntic gastritis, and the activity of antral gastritis (P = 0.024). However, in the multivariate analysis, the gene remained associated only with cagA-positive status (P = 0.012; OR, 5.54; 95% CI, 1.46 to 21.01). On the other hand, the intensity of gastritis in both the antral (P = 0.02) and oxyntic (P = 0.008) gastric mucosae, as well as the activity of antral (P < 10−3) and oxyntic (P < 10−3) gastritis, was significantly greater in patients colonized by a cagA-positive strain than in patients colonized by a cagA-negative strain.

DISCUSSION

H. pylori infection is associated with clinical outcomes as different as distal gastric carcinoma and duodenal ulcer. Among the factors that may be linked to infection outcome, bacterial virulence factors such as cytotoxin and the cag PAI have been extensively investigated. Although these known bacterial markers undoubtedly contribute to the genesis of H. pylori-associated diseases, they do not explain the entire process and do not distinguish between the two key outcomes. Thus, studies focusing on new putative bacterial virulence determinants are still desirable. Furthermore, identification of bacterial factors implicated in the evolution of H. pylori infection is one of the steps in understanding the interaction between the bacterium and the host cell.

Like the cag PAI, the plasticity region of H. pylori displays some characteristics of a PAI, i.e., large size and a lower percentage of G+C DNA than in the rest of the bacterial genome. This region also contains 46 and 48% of the genes that are unique to H. pylori strains 26695 and J99, respectively. These strain-specific genes may encode factors contributing to different disease outcomes, thus becoming virulence factor candidates.

In fact, in a previous study, Occhialini et al. (23) found that the JHP947 gene was present more frequently in strains isolated from patients with gastric adenocarcinoma (64.7%; 11 of 17) than in those isolated from patients with gastritis alone (34.6%; 9 of 26). In this study, in which a large number of patients was evaluated, we confirmed the association between the presence of JHP947-positive H. pylori strains and gastric carcinoma. However, in contrast to the study of Occhialini et al., the present methodology did not permit definitive conclusions to be reached regarding the association between the JHP940 gene and gastric carcinoma or between the HP986 gene and gastritis. These discordant results may be explained by differences between the plasticity regions of H. pylori strains isolated in distinct geographic areas, and they show the need to study different populations. However, there is also considerable geographic diversity among H. pylori gene sequences, and therefore failure to obtain a PCR product with a single pair of PCR primers does not necessarily mean that a gene is absent. It seems possible that one or both PCR primers might not anneal optimally with the corresponding sequences in these Brazilian isolates. Further experimental work needs to be done in order to investigate whether the JHP940 and HP986 genes are really absent from the Brazilian isolates. We tried, unsuccessfully, to amplify these genes with another set of PCR primers. In the future, Southern hybridizations could be used to confirm the results for these two genes.

In this study we demonstrated for the first time an association between the presence of the JHP947 gene and duodenal ulcer. Therefore, the JHP947 gene, as well as the cagA gene, which is a marker of the cag PAI, may be implicated in the development of both duodenal ulcer and gastric carcinoma.

In a case control study carried out in Brazil, Queiroz et al. (29) observed a significant association between cagA-positive status and distal gastric carcinoma. In addition, an association between infection with a cagA-positive H. pylori strain and duodenal ulcer was shown in another case control study with Brazilian children (27). Several other studies have demonstrated such associations (7, 9, 10, 18, 25, 26, 34). Infection with cagA-positive H. pylori strains that contain the cag PAI elicits a marked inflammatory response with a higher density of polymorphonuclear cells on the gastric mucosa, which has been considered a risk factor for the development of these severe diseases.

Our results showed that the presence of the JHP947 gene was associated with the cagA-positive genotype. However, the high degree of gastritis that was associated with the presence of both genes in the univariate analysis did not remain associated with the JHP947 gene in the full model of logistic regression, showing that the severity of the microscopic alterations of the gastric mucosae was associated only with the presence of the cagA gene. Salama et al. (30) analyzed 15 strains by whole-genome microarray and found genes (strain-specific and also candidate virulence genes) that were coinherited with the cag PAI, like the JHP947 gene, but they did not identify genes associated with specific diseases; this may be due to the small sample size and the lack of clinical information for many of the strains evaluated. Thus, although the JHP947 gene is a true gene which was previously found to be expressed by reverse transcription-PCR (23), its putative function does not seem to be correlated with the severity of the gastric inflammation caused by H. pylori infection. The findings that we observed, however, provide a framework for future studies that would more mechanistically delineate the role of this locus in the diseases associated with H. pylori. It also has to be emphasized that although the plasticity region of H. pylori is an unstable locus, Israel et al. demonstrated in a recent study (14) that the JHP947 gene, which was present in the original J99 H. pylori strain, remained present 6 years later.

In conclusion, this study confirmed the association of a new ORF with gastric carcinoma in a large number of strains and demonstrated that this gene was also associated with duodenal peptic ulcer. In addition to the cag PAI and VacA cytotoxin, which are recognized virulence markers, the JHP947 gene is a novel virulence marker candidate of H. pylori. Functional analysis of the gene potentially identified as a novel pathogenicity marker will provide insight into its role in the virulence of H. pylori and the evolution of the infection.

Acknowledgments

This work was supported by grants from CAPES, CNPq, and FAPEMIG in Brazil and from Cofecub, Association pour la Recherche contre le Cancer (ARC), and Conseil Régional d'Aquitaine in France.

We acknowledge the surgeons of the University Hospital, UFMG, and the Luxemburgo Hospital of Oncology, Belo Horizonte, Brazil, who kindly assisted in the collection of stomach samples. We also thank the undergraduate assistants and Ana Maria Brás Esteves, a technician at the Laboratory of Research in Bacteriology, for initial processing of the material and for bacterial cultures, respectively.

REFERENCES

  • 1.Alm, R. A., and T. J. Trust. 1999. Analysis of the genetic diversity of Helicobacter pylori: the tale of two genomes. J. Mol. Med. 77:834-846. [DOI] [PubMed] [Google Scholar]
  • 2.Alm, R. A., L.-S. L. Ling, D. T. Moir, B. L. King, E. D. Brown, P. C. Doig, D. R. Smith, B. Noonan, B. C. Guild, B. L. De Jonge, G. Carmel, P. J. Tummino, A. Caruso, M. Uria-Nickelsen, D. M. Mills, C. Ives, R. Gibson, D. Melberg, S. D. Mills, Q. Jiang, D. E. Taylor, G. F. Vovis, and T. J. Trust. 1999. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 397:176-180. [DOI] [PubMed] [Google Scholar]
  • 3.Atherton, J. C., P. Cao, R. M. Peek, M. K. R. Tummuru, M. J. Blaser, and T. L. Cover. 1995. Mosaicism in vacuolatin cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270:17771-17777. [DOI] [PubMed] [Google Scholar]
  • 4.Atherton, J. C., R. M. Peek, K. T. Tham, T. L. Cover, and M. J. Blaser. 1997. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 112:92-99. [DOI] [PubMed] [Google Scholar]
  • 5.Censini, S., C. Lange, Z. Xiang, J. E. Crabtree, P. Ghiara, M. Borodovsky, R. Rappuoli, and A. Covacci. 1996. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA 93:14648-14653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Clayton, C. L., H. Kleanthous, P. J. Coates, D. D. Morgan, and S. Tabaqchali. 1992. Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J. Clin. Microbiol. 30:192-200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Cover, T. L., Y. Glupczynski, A. P. Lage, A. Burette, M. K. R. Tummuru, G. I. Perez-Perez, and M. J. Blaser. 1995. Serological detection of infection with cagA+ Helicobacter pylori strains. J. Clin. Microbiol. 33:1496-1500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Dixon, M. F., R. M. Genta, J. H. Yardley, and P. Correa. 1996. Classification and grading of gastritis—the updated Sydney system. Am. J. Surg. Pathol. 20:1161-1181. [DOI] [PubMed] [Google Scholar]
  • 9.Evans, D. G., D. M. Queiroz, E. N. Mendes, and D. J. Evans, Jr. 1998. Helicobacter pylori cagA status and s and m alleles of vacA in isolates from individuals with a variety of H. pylori-associated gastric diseases. J. Clin. Microbiol. 36:3435-3437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Figueroa, G., M. Troncoso, M. S. Toledo, G. Faundez, and R. Acuna. 2002. Prevalence of serum antibodies to Helicobacter pylori VacA and CagA and gastric diseases in Chile. J. Med. Microbiol. 51:300-304. [DOI] [PubMed] [Google Scholar]
  • 11.Graham, D. Y. 1997. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 113:1983-1991. [DOI] [PubMed] [Google Scholar]
  • 12.Gusmão, V. R., E. N. Mendes, D. M. M. Queiroz, G. A. Rocha, A. M. C. Rocha, A. A. R. Ashour, and A. S. T. Carvalho. 2000. vacA genotypes in Helicobacter pylori strains isolated from children with and without duodenal ulcer in Brazil. J. Clin. Microbiol. 38:2853-2857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ikeno, T., H. Ota, A. Sugiyama, K. Ishida, T. Katsuyama, R. M. Genta, and S. Kawasaki. 1999. Helicobacter pylori-induced chronic active gastritis, intestinal metaplasia and gastric ulcer in Mongolian gerbils. Am. J. Pathol. 154:951-960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Israel, D. A., N. Salama, U. Krishna, U. M. Rieger, J. C. Atherton, S. Falkow, and R. M. Peek, Jr. 2001. Helicobacter pylori genetic diversity within the gastric niche of a single human host. Proc. Natl. Acad. Sci. USA 98:14625-14630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kuipers, E. J. 1999. Exploring the link between Helicobacter pylori and gastric cancer. Aliment. Pharmacol. Ther. 13:3-11. [DOI] [PubMed] [Google Scholar]
  • 16.Kume, K., M. Hirakoba, I. Murata, I. Yoshikawa, and M. Otsuki. 2001. Disappearance of both MALT lymphoma and hyperplastic polyps in the stomach after eradication of Helicobacter pylori. Am. J. Gastroenterol. 96:2796-2797. [DOI] [PubMed] [Google Scholar]
  • 17.Matysiak-Budnik, T., and F. Mégraud. 1997. Epidemiology of Helicobacter pylori with special reference to professional risk. J. Physiol. Pharmacol. 48:3-17. [PubMed] [Google Scholar]
  • 18.Miehlke, S., C. Kirsch, K. Agha-Amiri, T. Günther, N. Lehn, P. Malfertheiner, M. Stolte, G. Ehninger, and E. Bayerdörffer. 2000. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int. J. Cancer 87:322-327. [PubMed] [Google Scholar]
  • 19.Miehlke, S., E. Bayerdörffer, G. Ehninger, and M. Stolte. 2001. Precancerous risk markers in Helicobacter pylori gastritis. Pathology 22:31-36. [DOI] [PubMed] [Google Scholar]
  • 20.Monteiro, L., N. Gras, R. Vidal, J. Cabrita, and F. Mégraud. 2001. Detection of Helicobacter pylori DNA in human feces by PCR: DNA stability and removal of inhibitors. J. Microbiol. Methods 45:89-94. [DOI] [PubMed] [Google Scholar]
  • 21.Nomura, A., G. N. Stemmermann, P. H. Chyou, I. Kato, G. I. Perez-Perez, and M. J. Blaser. 1991. Helicobacter pylori infection and gastric carcinoma in a population of Japanese-Americans in Hawaii. N. Engl. J. Med. 325:1132-1136. [DOI] [PubMed] [Google Scholar]
  • 22.Occhialini, A., A. Marais, M. Urdaci, R. Sierra, N. Munoz, A. Covacci, and F. Mégraud. 2001. Composition and gene expression of the cag pathogenicity island in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica. Infect. Immun. 69:1902-1908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Occhialini, A., A. Marais, R. Alm, F. Garcia, R. Sierra, and F. Mégraud. 2000. Distribution of open reading frames of plasticity region of strain J99 in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica. Infect. Immun. 68:6240-6249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Parsonnet, J., G. D. Friedman, D. P. Vandersteen, Y. Chang, J. H. Volgeman, N. Orentreich, and K. S. Richard. 1991. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325:1127-1131. [DOI] [PubMed] [Google Scholar]
  • 25.Parsonnet, J., G. D. Friedman, N. Orentreich, and H. Volgeman. 1997. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40:297-301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Prinz, C., M. Schoniger, R. Rad, I. Becker, E. Keiditsch, S. Wagenpfeil, M. Classen, T. Rosh, W. Schepp, and M. Gerhard. 2001. Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res. 61:1903-1909. [PubMed] [Google Scholar]
  • 27.Queiroz, D. M., E. N. Mendes, A. S. T. Carvalho, G. A. Rocha, A. M. R. Oliveira, T. F. Soares, A. Santos, M. M. D. A. Cabral, and A. M. M. F. Nogueira. 2000. Factors associated with Helicobacter pylori infection by a cagA-positive strain in children. J. Infect. Dis. 181:626-630. [DOI] [PubMed] [Google Scholar]
  • 28.Queiroz, D. M., E. N. Mendes, and G. A. Rocha. 1987. Indicator medium for isolation of Campylobacter pylori. J. Clin. Microbiol. 25:2378-2379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Queiroz, D. M., E. N. Mendes, G. A. Rocha, A. M. Oliveira, C. A. Oliveira, P. P. Magalhães, S. B. Moura, M. M. Cabral, and A. M. Nogueira. 1998. cagA-positive Helicobacter pylori and risk for developing gastric carcinoma in Brazil. Int. J. Cancer 78:135-139. [DOI] [PubMed] [Google Scholar]
  • 30.Salama, N., K. Guillemin, T. K. McDaniel, G. Sherlock, L. Tompkins, and S. Falkow. 2000. A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains. Proc. Natl. Acad. Sci. USA 97:14668-14673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Tomb, J.-F., O. White, A. R. Kerlavage, R. A. Clayton, G. G. Sutton, R. D. Fleischmann, K. A. Ketchun, H. P. Klenk, S. Gill, B. A. Dougherty, K. Nelson, J. Quackenbush, L. Zhou, E. F. Kirkness, S. Peterson, B. Loftus, D. Richardson, R. Dodson, H. G. Khalak, A. Glodek, K. McKenney, L. M. Fitzegerald, N. Lee, M. D. Adams, E. K. Hickey, D. E. Berg, J. D. Gocayne, T. R. Utterback, J. D. Peterson, J. M. Kelley, M. D. Cotton, J. M. Weidman, C. Fujii, C. Bowman, L. Watthey, E. Wallin, W. S. Hayes, M. Borodovsky, P. D. Karp, H. O. Smith, C. M. Fraser, and J. C. Venter. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:539-547. [DOI] [PubMed] [Google Scholar]
  • 32.Tummuru, M. K., T. L. Cover, and M. J. Blaser. 1993. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect. Immun. 61:1799-1809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Uemura, N., S. Okamoto, S. Yamamoto, N. Matsumura, S. Yamaguchi, M. Yamakido, K. Taniyama, N. Sasaki, and R. J. Schlemper. 2001. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345:784-789. [DOI] [PubMed] [Google Scholar]
  • 34.van Doorn, L.-J., C. Figueiredo, R. Sanna, A. Plaisier, P. Schoneeberger, W. de Boer, and W. Quint. 1998. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 115:58-66. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES